Takeda Q1 Profit Up, Keeps Flat Year Forecast

Japan’s largest drug maker, Takeda Pharmaceutical Co. Ltd. (4502.T: Quote, Profile, Research) , said on Friday quarterly profit rose 11.5 percent on strong sales of its high-margin Actos diabetes drug and anti-hypertension drug Blopress.

MORE ON THIS TOPIC